The aforementioned effects of fludarabine significantly improved NDV-mediated antitumor immunity and prolonged survival in mouse model of HCC. The findings indicate the utility of fludarabine as an adjuvant for oncolytic anticancer viro-immunotherapy.
Countstar Connection
Cell number and viability were quantified in the study's cell samples with Countstar (model not specified) during quality assessment for the cancer-model experiments.
